tiprankstipranks
Trending News
More News >
Immunotech Biopharm Ltd (HK:6978)
:6978
Hong Kong Market
Advertisement

Immunotech Biopharm Ltd (6978) Price & Analysis

Compare
1 Followers

6978 Stock Chart & Stats


Financials

6978 FAQ

What was Immunotech Biopharm Ltd’s price range in the past 12 months?
Immunotech Biopharm Ltd lowest stock price was HK$1.50 and its highest was HK$6.15 in the past 12 months.
    What is Immunotech Biopharm Ltd’s market cap?
    Immunotech Biopharm Ltd’s market cap is HK$2.04B.
      When is Immunotech Biopharm Ltd’s upcoming earnings report date?
      Immunotech Biopharm Ltd’s upcoming earnings report date is Aug 22, 2025 which is in 35 days.
        How were Immunotech Biopharm Ltd’s earnings last quarter?
        Currently, no data Available
        Is Immunotech Biopharm Ltd overvalued?
        According to Wall Street analysts Immunotech Biopharm Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Immunotech Biopharm Ltd pay dividends?
          Immunotech Biopharm Ltd does not currently pay dividends.
          What is Immunotech Biopharm Ltd’s EPS estimate?
          Immunotech Biopharm Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Immunotech Biopharm Ltd have?
          Immunotech Biopharm Ltd has 514,584,000 shares outstanding.
            What happened to Immunotech Biopharm Ltd’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Immunotech Biopharm Ltd?
            Currently, no hedge funds are holding shares in HK:6978

            Immunotech Biopharm Ltd Stock Smart Score

            6
            Neutral
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Positive
            20 days / 200 days
            Momentum
            32.78%
            12-Months-Change

            Fundamentals

            Return on Equity
            -228.99%
            Trailing 12-Months
            Asset Growth
            -35.58%
            Trailing 12-Months

            Company Description

            Immunotech Biopharm Ltd

            Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People's Republic of China. Its core product is EAL, a multi-target cellular immunotherapy product that is in Phase II clinical trials for the prevention of postsurgical recurrence of liver cancer. The company is also conducting pre-clinical and clinical trial studies for EAL to treat lung cancer, glioma, gastric cancer, and colorectal cancer. In addition, it develops 6B11-OCIK injection that is in Phase I clinical trial for ovarian cancer; CAR-T-19 injection product for B-cell acute lymphoblastic leukaemia; and TCR-T cell series products to treat solid tumors. The company was founded in 2006 and is headquartered in Beijing, the People's Republic of China.
            Similar Stocks
            Company
            Price & Change
            Follow
            TOT BIOPHARM International Co. Ltd.
            Jiangsu Recbio Technology Co., Ltd. Class H
            Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
            SinoMab Bioscience Ltd.
            Zhaoke Ophthalmology Ltd.
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis